Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07273214

Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt

This study aims to assess the knowledge, attitude, and practice (KAP) of third-trimester pregnant women toward self-medication in Assiut, Egypt. Self-medication is a common behavior among pregnant women, often influenced by cultural habits, easy access to medications, and limited awareness of potential risks.

Through a structured, interviewer-administered questionnaire, this cross-sectional study will collect data on the prevalence and pattern of self-medication, types of medications used, reasons for use, and sources of information. Participants will be recruited from antenatal care (ANC) clinics at Assiut University Hospital and selected primary health care centers.

The findings of this research will help identify gaps in awareness and guide educational interventions to promote safe medication practices during pregnancy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

About this study

Self-medication during pregnancy is a significant public health concern, as inappropriate use of medications can lead to adverse maternal and fetal outcomes. In developing countries, including Egypt, the availability of over-the-counter drugs, social beliefs, and lack of regulatory control contribute to this problem. However, data describing the magnitude and determinants of self-medication among pregnant women in Upper Egypt are limited.

This prospective cross-sectional study will be conducted among third-trimester pregnant women attending antenatal clinics at Assiut University Hospital and selected primary health care centers in Assiut, Egypt. A structured, pretested questionnaire will be used to collect data through face-to-face interviews by trained researchers.

The questionnaire covers sociodemographic data, obstetric history, knowledge about medication use during pregnancy, attitudes toward self-medication, and actual self-medication practices. It also includes items about commonly used drug types, sources of information, and reasons for self-medication.

A total of approximately 420 participants will be recruited using convenience sampling. Data will be analyzed using IBM SPSS version 29. Descriptive and inferential statistics will be applied to identify significant associations between self-medication practices and participant characteristics.

The study aims to:

Determine the prevalence of self-medication among third-trimester pregnant women.

Assess knowledge and attitudes regarding medication safety during pregnancy.

Identify the common drugs used and reasons for self-medication.

Provide recommendations for awareness and health education programs targeting pregnant women.

Ethical approval has been obtained from the Faculty of Medicine, Assiut University. Written informed consent will be obtained from all participants before enrollment. No intervention or experimental drug will be administered, and participant confidentiality will be maintained throughout the study.

The results of this research will contribute to improving antenatal care and maternal health policies by emphasizing the need for education about rational medication use during pregnancy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women in the third trimester (≥28 weeks of gestation)
  • Attending antenatal care at Assiut University Hospital or selected primary health centers during the study period
  • Willing to participate and able to provide informed consent

Exclusion criteria

  • Pregnant women with known psychiatric disorders or cognitive impairment that may affect questionnaire reliability.
  • Women with severe obstetric complications requiring emergency management.
  • Women unwilling to participate or unable to complete the interview.

Treatment and study plan

Structured Questionnaire on Self-Medication During Pregnancy

Other

A structured, pretested interviewer-administered questionnaire designed to assess the knowledge, attitude, and practice (KAP) of pregnant women in their third trimester regarding self-medication during pregnancy. The tool includes sections on sociodemographic data, pregnancy history, knowledge of medication use, attitudes toward drug safety, and patterns of self-medication. It is used once during a single face-to-face interview. No drug, biological, or device is administered.

Primary outcomes

  1. Prevalence of self-medication among third-trimester pregnant women

    Time frame: from 28-40 weeks of gestation

    The primary outcome will be the proportion (%) of third-trimester pregnant women who report self-medicating with any pharmaceutical or herbal product during their current pregnancy. Data will be collected using a structured interviewer-administered questionnaire assessing medication type, reason for use, and source of information. Prevalence will be calculated as the number of women reporting self-medication divided by the total number of surveyed participants.

Study contacts

Contact information is provided by the study sponsor or research team.

may mohammed abdelwahab, resident

CONTACT

[email protected]

01004231328

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt: A Cross-Sectional Observational Study

Acronym: SM-PREG

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Dec 9, 2025
Registry last updated
Dec 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.